ITK and neoplasm: Since ICB mediates its therapeutic effect by reinvigorating exhausted CTL and chronic TCR signaling is a major driver of such exhaustion16,17, we investigated whether inhibiting ITK, an important kinase that regulates TCR signaling18, would enhance the anti-tumor effect of ICB in ICB-resistant C57BL/6 mouse tumor models.